NanoString Technology Introduces Novel Solution for microRNA Research
Nanostring Technologies, Inc., announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the applications for its nCounter Analysis System, at the American Association for Cancer Research annual meeting.
MicroRNA (miRNAs) are small, single-stranded, non-coding RNA molecules that have generated intense interest in the scientific community for their recently discovered roles in tumor formation and important biological processes. The primary application areas of miRNA studies are in cancer, neurobiology, developmental biology, and stem cell research.
The nCounter miRNA Expression Assay Kits enabkle researchers to perform highly multiplexed, direct digital detection and counting of miRNA at single-base resolution, without the need for PCR amplification. NanoString’s Human miRNA Expression Assay kit enables researchers to profile more than 700 human and human viral miRNAs with specificity and sensitive comaparable to qPCR at a fraction of the cost.
Carlo Croce, a leading miRNA researcher, was part of an early access program for the Human miRNA Expression Assay Kit on the nCounter Analysis System at the Ohio State University Comprehensive Cancer Center Nucleic Acids Shared Resource directed by Hansjuerg Alder.
The nCounter Analysis System is a fully automated target profiling system that is extraordinarily easy to use. The reagents and consumables required to conduct miRNA and gene expression experiments. In addition to the new miRNA assays, the company is developing assays for copy number variation. NanoString also offers custom and off-the shelf assays for gene expression analysis. More information is available at www.nanostring.com.
MicroRNA (miRNAs) are small, single-stranded, non-coding RNA molecules that have generated intense interest in the scientific community for their recently discovered roles in tumor formation and important biological processes. The primary application areas of miRNA studies are in cancer, neurobiology, developmental biology, and stem cell research.
The nCounter miRNA Expression Assay Kits enabkle researchers to perform highly multiplexed, direct digital detection and counting of miRNA at single-base resolution, without the need for PCR amplification. NanoString’s Human miRNA Expression Assay kit enables researchers to profile more than 700 human and human viral miRNAs with specificity and sensitive comaparable to qPCR at a fraction of the cost.
Carlo Croce, a leading miRNA researcher, was part of an early access program for the Human miRNA Expression Assay Kit on the nCounter Analysis System at the Ohio State University Comprehensive Cancer Center Nucleic Acids Shared Resource directed by Hansjuerg Alder.
The nCounter Analysis System is a fully automated target profiling system that is extraordinarily easy to use. The reagents and consumables required to conduct miRNA and gene expression experiments. In addition to the new miRNA assays, the company is developing assays for copy number variation. NanoString also offers custom and off-the shelf assays for gene expression analysis. More information is available at www.nanostring.com.
No comments:
Post a Comment